190 related articles for article (PubMed ID: 37278910)
1. Skin and gut microbial associations with squamous cell carcinoma in solid organ transplant recipients.
Ha MV; McCormick TS; Salem I; Al-Shakhshir H; Ghannoum MA; Carroll BT
Arch Dermatol Res; 2023 Nov; 315(9):2709-2713. PubMed ID: 37278910
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
Cheng JY; Li FY; Ko CJ; Colegio OR
JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).
Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D
J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646
[TBL] [Abstract][Full Text] [Related]
4. Skin Cancer Development Is Strongly Associated with Actinic Keratosis in Solid Organ Transplant Recipients: A Danish Cohort Study.
Wenande E; Togsverd-Bo K; Hastrup A; Lei U; Philipsen PA; Haedersdal M
Dermatology; 2023; 239(3):393-402. PubMed ID: 36731451
[TBL] [Abstract][Full Text] [Related]
5. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
[TBL] [Abstract][Full Text] [Related]
6. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous squamous cell carcinomas in solid organ transplant recipients: emerging strategies for surveillance, staging, and treatment.
Kim C; Cheng J; Colegio OR
Semin Oncol; 2016 Jun; 43(3):390-4. PubMed ID: 27178693
[TBL] [Abstract][Full Text] [Related]
8. Comment on "Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)".
Longo MI; Wen X; Womer KL
J Am Acad Dermatol; 2016 May; 74(5):e105-6. PubMed ID: 27085243
[No Abstract] [Full Text] [Related]
9. Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study.
Rizvi SMH; Aagnes B; Holdaas H; Gude E; Boberg KM; Bjørtuft Ø; Helsing P; Leivestad T; Møller B; Gjersvik P
JAMA Dermatol; 2017 Dec; 153(12):1270-1277. PubMed ID: 29049612
[TBL] [Abstract][Full Text] [Related]
10. Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy.
Willey A; Mehta S; Lee PK
Dermatol Surg; 2010 May; 36(5):652-8. PubMed ID: 19889154
[TBL] [Abstract][Full Text] [Related]
11. Polygenic Risk Scores Stratify Keratinocyte Cancer Risk among Solid Organ Transplant Recipients with Chronic Immunosuppression in a High Ultraviolet Radiation Environment.
Seviiri M; Law MH; Ong JS; Gharahkhani P; Nyholt DR; Hopkins P; Chambers D; Campbell S; Isbel NM; Soyer HP; Olsen CM; Ellis JJ; Whiteman DC; Green AC; MacGregor S
J Invest Dermatol; 2021 Dec; 141(12):2866-2875.e2. PubMed ID: 34089721
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous squamous cell carcinoma in the organ transplant recipient.
Bibee K; Swartz A; Sridharan S; Kurten CHL; Wessel CB; Skinner H; Zandberg DP
Oral Oncol; 2020 Apr; 103():104562. PubMed ID: 32065978
[TBL] [Abstract][Full Text] [Related]
13. Skin Cancer in Non-White Solid Organ Transplant Recipients: Mayo Clinic Experience.
Zieman D; Heckman M; Brushaber D; Degesys C; Tolaymat L
South Med J; 2023 Oct; 116(10):839-844. PubMed ID: 37788820
[TBL] [Abstract][Full Text] [Related]
14. Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients.
Lanz J; Bouwes Bavinck JN; Westhuis M; Quint KD; Harwood CA; Nasir S; Van-de-Velde V; Proby CM; Ferrándiz C; Genders RE; Del Marmol V; Forchetti G; Hafner J; Vital DG; Hofbauer GFL
JAMA Dermatol; 2019 Jan; 155(1):66-71. PubMed ID: 30516812
[TBL] [Abstract][Full Text] [Related]
15. Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe-International Transplant Skin Cancer Collaborative metastases study, a prospective multicenter study.
de Jong E; Genders R; Harwood CA; Green AC; Plasmeijer EI; Proby C; Geissler E; Ferrándiz-Pulido C; Ducroux E; Euvrard S; Geusau A; Jahn-Bassler K; Borik-Heil L; Rácz E; Nägeli M; Hofbauer GFL; Piaserico S; Russo I; Mackintosh L; Borges-Costa J; Angeliki-Gkini M; Zavattaro E; Savoia P; Imko-Walszuk B; Dębska-Slizień A; Garmyn M; van Kelst S; Ricar J; Cetkovska P; Matin R; Güleç AT; Seçkin D; Anene CA; Oliveira WRP; Rademaker M; Goeman J; van Geloven N; Ruiz E; Murad F; Karn E; Schmults CD; Bouwes Bavinck JN
J Am Acad Dermatol; 2024 Jun; 90(6):1200-1209. PubMed ID: 38301923
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients.
Herman S; Rogers HD; Ratner D
Skinmed; 2007; 6(5):234-8. PubMed ID: 17786101
[TBL] [Abstract][Full Text] [Related]
17. Risk of Rare Cancers Among Solid Organ Transplant Recipients.
D'Arcy ME; Castenson D; Lynch CF; Kahn AR; Morton LM; Shiels MS; Pfeiffer RM; Engels EA
J Natl Cancer Inst; 2021 Feb; 113(2):199-207. PubMed ID: 32462187
[TBL] [Abstract][Full Text] [Related]
18. Low-Dose Acitretin for Secondary Prevention of Keratinocyte Carcinomas in Solid-Organ Transplant Recipients.
Solomon-Cohen E; Reiss-Huss S; Hodak E; Davidovici B
Dermatology; 2022; 238(1):161-166. PubMed ID: 33902035
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic options to decrease actinic keratosis and squamous cell carcinoma incidence and progression in solid organ transplant recipients: a practical approach.
Ritchie SA; Patel MJ; Miller SJ
Dermatol Surg; 2012 Oct; 38(10):1604-21. PubMed ID: 22646842
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
Schauder DM; Kim J; Nijhawan RI
JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]